Charlie E. Massie

4.2k total citations
8 papers, 154 citations indexed

About

Charlie E. Massie is a scholar working on Pulmonary and Respiratory Medicine, Molecular Biology and Cancer Research. According to data from OpenAlex, Charlie E. Massie has authored 8 papers receiving a total of 154 indexed citations (citations by other indexed papers that have themselves been cited), including 4 papers in Pulmonary and Respiratory Medicine, 3 papers in Molecular Biology and 3 papers in Cancer Research. Recurrent topics in Charlie E. Massie's work include Prostate Cancer Treatment and Research (4 papers), Epigenetics and DNA Methylation (2 papers) and RNA modifications and cancer (1 paper). Charlie E. Massie is often cited by papers focused on Prostate Cancer Treatment and Research (4 papers), Epigenetics and DNA Methylation (2 papers) and RNA modifications and cancer (1 paper). Charlie E. Massie collaborates with scholars based in United Kingdom, Belgium and South Sudan. Charlie E. Massie's co-authors include Vincent J. Gnanapragasam, Anne Y. Warren, Andy G. Lynch, Kevin W. Loudon, Julia Jones, Satoshi Hori, Paul Coupland, Katarzyna Kania, Xiao Tan and Anne George and has published in prestigious journals such as The Lancet, British Journal of Cancer and Cell Reports.

In The Last Decade

Charlie E. Massie

8 papers receiving 153 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Charlie E. Massie United Kingdom 6 87 63 54 33 32 8 154
Rajni Sonavane United States 6 80 0.9× 54 0.9× 35 0.6× 42 1.3× 36 1.1× 6 152
Cody Weimholt United States 7 91 1.0× 67 1.1× 33 0.6× 63 1.9× 32 1.0× 15 168
Ana Remírez Spain 7 76 0.9× 48 0.8× 48 0.9× 37 1.1× 33 1.0× 9 151
Núria Pedrola Spain 5 73 0.8× 49 0.8× 51 0.9× 29 0.9× 15 0.5× 5 145
Maria D. Fenor de la Maza United Kingdom 7 53 0.6× 85 1.3× 32 0.6× 56 1.7× 17 0.5× 17 152
Nikul Patel United States 6 68 0.8× 77 1.2× 42 0.8× 44 1.3× 20 0.6× 6 161
Christian Veltkamp Germany 5 103 1.2× 34 0.5× 49 0.9× 62 1.9× 29 0.9× 6 163
Øystein Størkersen Norway 8 81 0.9× 145 2.3× 65 1.2× 32 1.0× 19 0.6× 13 247
Jason Laskey United States 4 79 0.9× 44 0.7× 20 0.4× 37 1.1× 20 0.6× 4 109
David T. Hoang United States 5 114 1.3× 113 1.8× 64 1.2× 76 2.3× 14 0.4× 7 256

Countries citing papers authored by Charlie E. Massie

Since Specialization
Citations

This map shows the geographic impact of Charlie E. Massie's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Charlie E. Massie with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Charlie E. Massie more than expected).

Fields of papers citing papers by Charlie E. Massie

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Charlie E. Massie. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Charlie E. Massie. The network helps show where Charlie E. Massie may publish in the future.

Co-authorship network of co-authors of Charlie E. Massie

This figure shows the co-authorship network connecting the top 25 collaborators of Charlie E. Massie. A scholar is included among the top collaborators of Charlie E. Massie based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Charlie E. Massie. Charlie E. Massie is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

8 of 8 papers shown
1.
Lleshi, Ermira, Robert L. Hanson, Radosław Lach, et al.. (2024). Prostate cancer detection through unbiased capture of methylated cell-free DNA. iScience. 27(7). 110330–110330. 5 indexed citations
2.
Tuong, Zewen Kelvin, Kevin W. Loudon, Brendan Berry, et al.. (2021). Resolving the immune landscape of human prostate at a single-cell level in health and cancer. Cell Reports. 37(12). 110132–110132. 68 indexed citations
3.
Liu, Shiqin, Michelle Shen, En‐Chi Hsu, et al.. (2020). Discovery of PTN as a serum-based biomarker of pro-metastatic prostate cancer. British Journal of Cancer. 124(5). 896–900. 28 indexed citations
4.
Tran, Maxine, B. Bibby, Lingjian Yang, et al.. (2020). Independence of HIF1a and androgen signaling pathways in prostate cancer. BMC Cancer. 20(1). 469–469. 28 indexed citations
5.
Smeets, Elien, Andy G. Lynch, Stefan Preković, et al.. (2017). The role of TET-mediated DNA hydroxymethylation in prostate cancer. Molecular and Cellular Endocrinology. 462(Pt A). 41–55. 15 indexed citations
6.
Nice, Francesca, Charlie E. Massie, Thorsten Klampfl, & Anthony R. Green. (2017). Determination of complex subclonal structures of hematological malignancies by multiplexed genotyping of blood progenitor colonies. Experimental Hematology. 57. 60–64.e1. 4 indexed citations
7.
Lamb, Alastair, Antonio Ramos‐Montoya, Roslin Russell, et al.. (2014). Role of Hes6 in castration-resistant prostate cancer. The Lancet. 383. S67–S67. 1 indexed citations
8.
Sharma, Neeti, Charlie E. Massie, Helen E. Scott, et al.. (2012). 942 The androgen receptor induces a distinct transcriptional program in castration resistant prostate cancer in man. European Urology Supplements. 11(1). e942–e942a. 5 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026